Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Discrepancies and Agreement in Perceptions of Implementation Leadership: Associations with Dosage of School-Based Evidence-Based Practices for Children with Autism.

Meza RD, Beidas RS, Ehrhart MG, Mandell DS, Dorsey S, Frederick L, Oh C, Locke J.

Adm Policy Ment Health. 2019 Jul;46(4):518-529. doi: 10.1007/s10488-019-00932-3.

PMID:
30953224
2.

Individual and organizational factors that affect implementation of evidence-based practices for children with autism in public schools: a cross-sectional observational study.

Locke J, Lawson GM, Beidas RS, Aarons GA, Xie M, Lyon AR, Stahmer A, Seidman M, Frederick L, Oh C, Spaulding C, Dorsey S, Mandell DS.

Implement Sci. 2019 Mar 13;14(1):29. doi: 10.1186/s13012-019-0877-3.

3.

Scrotoplasty at Time of Penile Implant is at High Risk for Dehiscence in Diabetics.

Gupta NK, Sulaver R, Welliver C, Kottwitz M, Frederick L, Dynda D, Köhler TS.

J Sex Med. 2019 Apr;16(4):602-608. doi: 10.1016/j.jsxm.2019.02.001. Epub 2019 Mar 7.

PMID:
30852109
4.

Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations.

Peterson JF, Rowsey RA, Marcou CA, Pearce KE, Williamson CM, Frederick LA, Greipp PT, Ketterling RP, Kumar S, Viswanatha DS, Polley MY, Fink JM, Reichard KK, Van Dyke DL, Baughn LB.

Blood Cancer J. 2019 Feb 19;9(3):20. doi: 10.1038/s41408-019-0182-z. No abstract available.

5.

Organizational culture and climate profiles: relationships with fidelity to three evidence-based practices for autism in elementary schools.

Williams NJ, Frank HE, Frederick L, Beidas RS, Mandell DS, Aarons GA, Green P, Locke J.

Implement Sci. 2019 Feb 12;14(1):15. doi: 10.1186/s13012-019-0863-9.

6.

The games they play: Observations of children with autism spectrum disorder on the school playground.

Gilmore S, Frederick LK, Santillan L, Locke J.

Autism. 2018 Nov 9:1362361318811987. doi: 10.1177/1362361318811987. [Epub ahead of print]

PMID:
30413135
7.

The first report of antifungal lipopeptide production by a Bacillus subtilis subsp. inaquosorum strain.

Knight CA, Bowman MJ, Frederick L, Day A, Lee C, Dunlap CA.

Microbiol Res. 2018 Nov;216:40-46. doi: 10.1016/j.micres.2018.08.001. Epub 2018 Aug 2.

PMID:
30269855
8.

The impact of implementation support on the use of a social engagement intervention for children with autism in public schools.

Locke J, Shih W, Kang-Yi CD, Caramanico J, Shingledecker T, Gibson J, Frederick L, Mandell DS.

Autism. 2019 May;23(4):834-845. doi: 10.1177/1362361318787802. Epub 2018 Jul 12.

PMID:
29998740
9.

Understanding Friendship Sex Heterophily and Relational Characteristics to Optimize the Selection of Peer Models for Children with Autism Spectrum Disorder.

Locke J, Anderson A, Frederick L, Kasari C.

J Autism Dev Disord. 2018 Dec;48(12):4010-4018. doi: 10.1007/s10803-018-3662-2.

10.

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?

Fang H, Kapoor P, Gonsalves WI, Frederick LA, Viswanatha D, Howard MT, He R, Morice WG 2nd, McPhail ED, Greipp PT, Ansell SM, Kyle RA, Gertz MA, Paludo J, Abeykoon J, King RL.

Am J Clin Pathol. 2018 Jul 3;150(2):168-176. doi: 10.1093/ajcp/aqy041.

PMID:
29868855
11.

Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience.

Oliveira JL, Coon LM, Frederick LA, Hein M, Swanson KC, Savedra ME, Porter TR, Patnaik MM, Tefferi A, Pardanani A, Grebe SK, Viswanatha DS, Hoyer JD.

Am J Hematol. 2018 May 23. doi: 10.1002/ajh.25150. [Epub ahead of print]

12.

Analysis of semen parameters during 2 weeks of daily ejaculation: a first in humans study.

Welliver C, Benson AD, Frederick L, Leader B, Tirado E, Feustel P, Kontio J, McAsey M, Köhler TS.

Transl Androl Urol. 2016 Oct;5(5):749-755.

13.

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.

King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG, Howard MT.

Am J Clin Pathol. 2016 Jun;145(6):843-51. doi: 10.1093/ajcp/aqw072. Epub 2016 Jun 21.

PMID:
27329639
14.

Contrasting regional and national mechanisms for predicting elevated arsenic in private wells across the United States using classification and regression trees.

Frederick L, VanDerslice J, Taddie M, Malecki K, Gregg J, Faust N, Johnson WP.

Water Res. 2016 Mar 15;91:295-304. doi: 10.1016/j.watres.2016.01.023. Epub 2016 Jan 13.

PMID:
26803265
15.

Potential impacts to perennial springs from tar sand mining, processing, and disposal on the Tavaputs Plateau, Utah, USA.

Johnson WP, Frederick LE, Millington MR, Vala D, Reese BK, Freedman DR, Stenten CJ, Trauscht JS, Tingey CE, Kip Solomon D, Fernandez DP, Bowen GJ.

Sci Total Environ. 2015 Nov 1;532:20-30. doi: 10.1016/j.scitotenv.2015.05.127. Epub 2015 Jun 5.

PMID:
26057623
16.

MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.

Pulido JS, Salomao DR, Frederick LA, Viswanatha DS.

Retina. 2015 Apr;35(4):624-7. doi: 10.1097/IAE.0000000000000589.

PMID:
25768255
17.

Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.

Frederick LR, Cakir OO, Arora H, Helfand BT, McVary KT.

J Sex Med. 2014 Oct;11(10):2546-53. doi: 10.1111/jsm.12647. Epub 2014 Jul 24.

PMID:
25059314
18.

Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm.

Frederick L, Beardell F, Viswanatha DS.

Hum Pathol. 2014 Aug;45(8):1784-9. doi: 10.1016/j.humpath.2014.04.017. Epub 2014 May 8.

PMID:
24927924
19.

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE.

Am J Hematol. 2014 Jul;89(7):757-65. doi: 10.1002/ajh.23737. Epub 2014 Apr 26.

20.

A case of a metanephric adenoma of the kidney surgically treated with robot-assisted laparoscopic partial nephrectomy.

Patel RD, Frederick L, Kohler T, Schwartz B.

Case Rep Urol. 2013;2013:703859. doi: 10.1155/2013/703859. Epub 2013 Sep 19.

21.

Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.

Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS.

Br J Haematol. 2013 Nov;163(3):326-33. doi: 10.1111/bjh.12534. Epub 2013 Aug 27.

22.

The woodwork effect: estimating it and controlling the damage.

Weissert WG, Frederick L.

J Aging Soc Policy. 2013;25(2):107-33. doi: 10.1080/08959420.2013.766073.

PMID:
23570506
23.

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL.

Blood. 2012 Sep 13;120(11):2280-9. doi: 10.1182/blood-2012-03-419937. Epub 2012 Aug 1.

24.

TP53 mutations and polymorphisms in primary myelofibrosis.

Raza S, Viswanatha D, Frederick L, Lasho T, Finke C, Knudson R, Ketterling R, Pardanani A, Tefferi A.

Am J Hematol. 2012 Feb;87(2):204-6. doi: 10.1002/ajh.22216. Epub 2011 Nov 4.

25.

A case of coronal urethral duplication with no other abnormalities.

Frederick L, Benson AD.

Can J Urol. 2011 Feb;18(1):5557-9.

PMID:
21333052
26.

Primary carcinoid tumor presenting as a nonpalpable testicular mass.

Frederick LR, Ballek NK, Esplin JA, Köhler TS.

J Clin Oncol. 2010 Nov 1;28(31):e637-9. doi: 10.1200/JCO.2010.29.7457. Epub 2010 Sep 20. No abstract available.

PMID:
20855827
27.

Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.

Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, Radisky DC, Fields AP.

Oncogene. 2008 Aug 14;27(35):4841-53. doi: 10.1038/onc.2008.119. Epub 2008 Apr 21.

28.

Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.

Fields AP, Frederick LA, Regala RP.

Biochem Soc Trans. 2007 Nov;35(Pt 5):996-1000. Review.

PMID:
17956262
29.

Bioindicators of immune function in creosote-adapted estuarine killifish, Fundulus heteroclitus.

Frederick LA, Van Veld PA, Rice CD.

J Toxicol Environ Health A. 2007 Sep;70(17):1433-42.

PMID:
17687729
30.

Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders.

Morice WG, Hanson CA, Kumar S, Frederick LA, Lesnick CE, Greipp PR.

Leukemia. 2007 Sep;21(9):2043-6. Epub 2007 Apr 26. No abstract available.

PMID:
17460704
31.

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases.

Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG.

Cell Signal. 2006 Jan;18(1):69-82. Epub 2005 May 31.

PMID:
15927447
32.

Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines.

Gilbert JA, Frederick LM, Pobst LJ, Ames MM.

Biochem Pharmacol. 2005 Apr 15;69(8):1159-66.

PMID:
15794936
33.

Disparate effects of two phosphatidylcholine binding proteins, C-reactive protein and surfactant protein A, on pulmonary surfactant structure and function.

Nag K, Rodriguez-Capote K, Panda AK, Frederick L, Hearn SA, Petersen NO, Schürch S, Possmayer F.

Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1145-53. Epub 2004 Aug 13.

34.

Prevalence and genotyping of Giardia duodenalis from beef calves in Alberta, Canada.

Appelbee AJ, Frederick LM, Heitman TL, Olson ME.

Vet Parasitol. 2003 Mar 25;112(4):289-94.

PMID:
12623208
35.
36.

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.

Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, Sila CA, Schulz GA, Roberts RS, Gent M.

Neurology. 2001 Nov 13;57(9):1603-10.

PMID:
11706099
37.

Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements.

Frederick L, Eley G, Wang XY, James CD.

Neuro Oncol. 2000 Jul;2(3):159-63. doi: 10.1093/neuonc/2.3.159.

38.

Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist.

Nicholson NS, Abood NA, Panzer-Knodle SG, Frederick LG, Page JD, Salyers AK, Suleymanov OD, Szalony JA, Taite BB, Anders RJ.

Med Res Rev. 2001 May;21(3):211-26.

PMID:
11301411
40.

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

Frederick L, Wang XY, Eley G, James CD.

Cancer Res. 2000 Mar 1;60(5):1383-7.

41.

Quality through metrics.

Frederick L, Kallal T, Krook H.

Qual Assur. 1999;7(1):5-16.

PMID:
10707373
42.

Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.

Raffel C, Frederick L, O'Fallon JR, Atherton-Skaff P, Perry A, Jenkins RB, James CD.

Clin Cancer Res. 1999 Dec;5(12):4085-90.

43.

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

James CD, Galanis E, Frederick L, Kimmel DW, Cunningham JM, Atherton-Skaff PJ, O'Fallon JR, Jenkins RB, Buckner JC, Hunter SB, Olson JJ, Scheithauer BW.

Int J Oncol. 1999 Sep;15(3):547-53.

PMID:
10427138
44.

Exploring the relationship between cultural values, beliefs, and practices and patient falls: a Middle Eastern study.

Hilliard DJ, Frederick L, Tierney-Gumaer R, Simpson MJ.

J Healthc Qual. 1999 Jan-Feb;21(1):42-8.

PMID:
10351222
45.

Induced expression of CYP2A5 in inflamed trematode-infested mouse liver.

Montero R, Gentile GJ, Frederick L, McMannis J, Murphy T, Silva G, Blankespoor H, Gentile JM.

Mutagenesis. 1999 Mar;14(2):217-20.

PMID:
10229924
46.

3' end structure and rearrangements of EGFR in glioblastomas.

Eley G, Frederick L, Wang XY, Smith DI, James CD.

Genes Chromosomes Cancer. 1998 Nov;23(3):248-54.

PMID:
9790506
47.

Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.

Frederick LG, Suleymanov OD, Szalony JA, Taite BB, Salyers AK, King LW, Feigen LP, Nicholson NS.

Circulation. 1998 Aug 25;98(8):813-20.

PMID:
9727553
48.

Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences.

Wang XY, Smith DI, Frederick L, James CD.

Oncogene. 1998 Jan 15;16(2):191-5.

49.

PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.

Liu W, James CD, Frederick L, Alderete BE, Jenkins RB.

Cancer Res. 1997 Dec 1;57(23):5254-7.

50.

Legal issues and remedies for victims of domestic violence.

Frederick LM, Farney AC.

Minn Med. 1997 Oct;80(10):47-51. No abstract available.

PMID:
9350134

Supplemental Content

Loading ...
Support Center